Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Serum Institute to seek DCGI market nod for qHPV vaccine against cervical cancer

Ruchika Sharma16 May 2022 11:26 AM IST

An official source aware of the development said if the government approves the SII's proposal, then it will save a significant amount of time to...

CDL Kasauli clears over 21 lakh Gennova Biopharma mRNA COVID vaccine doses: Sources

Ruchika Sharma15 May 2022 10:30 AM IST

Gennova's mRNA vaccine is an Omicron-specific vaccine and has already tweaked its mRNA platform that will target Omicron.

Bristol Myers Squibb to sell its East Syracuse facility to LOTTE

Ruchika Sharma15 May 2022 10:15 AM IST

Following the closing of the transaction, LOTTE, under a newly-established CDMO relationship, will manufacture product for Bristol Myers Squibb from...

PAG, partners to acquire controlling stake in Optimus Drugs for Rs 2,000 crore

Ruchika Sharma15 May 2022 10:00 AM IST

''The businesses of the two companies are highly complementary and will provide a solid foundation for the platform to make further acquisitions,'' it...

Moderna concludes USFDA submission for use of COVID vaccine in adolescents, kids

Ruchika Sharma15 May 2022 9:30 AM IST

New Delhi: Moderna Inc has made all necessary submissions required by the U.S. Food & Drug Administration for emergency use authorization of its...

Cipla net profit declines 12 percent to Rs 362 crore in Q4

Ruchika Sharma15 May 2022 9:00 AM IST

The company's domestic business continued the double digit trajectory during the quarter, he added.

Eli Lilly Mounjaro injection gets USFDA nod for type 2 diabetes

Ruchika Sharma14 May 2022 3:17 PM IST

Mounjaro will be available in six doses (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg) and will come in Lilly's auto-injector pen with a pre-attached,...

Drug alert: CDSCO flags 27 medicine batches as not of standard quality

Ruchika Sharma14 May 2022 2:48 PM IST

New Delhi: In its latest drug safety alert, the Central Drugs Standard Control Organization (CDSCO) has flagged 27 medicine batches as not of Standard...

SII, Symbiosis ink pact to set up vaccine research centre

Ruchika Sharma14 May 2022 11:23 AM IST

Symbiosis International University's faculty of health sciences dean Rajiv Yeravdekar said the initiative will help not only in addressing futuristic...

Generic drugmakers to sell Pfizer COVID drug Paxlovid for USD 25 or less in low-income countries

Ruchika Sharma14 May 2022 11:00 AM IST

CHAI said the $25 price ceiling would apply only if there is demand from the poorer countries for at least 1 million treatment courses a year.

Novavax seeks Taiwan FDA emergency use nod for COVID-19 vaccine

Ruchika Sharma14 May 2022 10:00 AM IST

United States: Novavax has announced the submission of a request for emergency use authorization to Taiwan's Food and Drug Administration for its...

Zydus unveils Bemdac to treat bad cholesterol in India

Ruchika Sharma13 May 2022 3:50 PM IST

Bempedoic acid has also shown to have good results in patients not able to tolerate statins and those who do not respond to statins.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok